M. Wallander

First name
M.
Middle name
A.
Last name
Wallander
Rodriguez, L. A. G., Wallander, M. A., Johanson, S., & Bjorck, S. (1997). Renal disease and acid-suppressing drugs. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/(sici)1099-1557(199707)6:4<247::aid-pds296>3.0.co;2-o
View
Rodriguez, L. A. G., Wallander, M. A., & Stricker, B. H. (1997). The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs. Br J Clin Pharmacol.
View
Rodriguez, L. A. G., Mannino, S., Wallander, M. A., & Lindblom, B. (1996). A cohort study of the ocular safety of anti-ulcer drugs. Br J Clin Pharmacol.
View
Rodriguez, L. A. G., Mannino, S., & Wallander, M. A. (1995). Ocular safety of antiulcer drugs. Lancet.
View
Ruigomez, A., Wallander, M. A., Johansson, S., & Rodriguez, L. A. G. (1999). One-year follow-up of newly diagnosed irritable bowel syndrome patients. Aliment Pharmacol Ther.
View
Ruigomez, A., Rodriguez, L. A. G., Cattaruzzi, C., Troncon, M. G., Agostinis, L., Wallander, M. A., & Johansson, S. (1999). Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol.
View
Rodriguez, L. A. G., Ruigomez, A., Hasselgren, G., Wallander, M. A., & Johansson, S. (1998). Comparison of mortality from peptic ulcer bleed between patients with or without peptic ulcer antecedents. Epidemiology.
View
Rodriguez, L. A. G., Ruigomez, A., Wallander, M. A., Johansson, S., & Olbe, L. (2000). Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol.
View
Ruigomez, A., Rodriguez, L. A. G., Hasselgren, G., Johansson, S., & Wallander, M. A. (2000). Overall mortality among patients surviving an episode of peptic ulcer bleeding. J Epidemiol Community Health.
View
Ruigomez, A., Johansson, S., Wallander, M. A., & Rodriguez, L. A. G. (2001). Gender and drug treatment as determinants of mortality in a cohort of heart failure patients. Eur J Epidemiol.
View